Does OCRELIZUMAB Cause Cerebral atrophy? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Cerebral atrophy have been filed in association with OCRELIZUMAB (OCREVUS). This represents 0.1% of all adverse event reports for OCRELIZUMAB.
48
Reports of Cerebral atrophy with OCRELIZUMAB
0.1%
of all OCRELIZUMAB reports
0
Deaths
11
Hospitalizations
How Dangerous Is Cerebral atrophy From OCRELIZUMAB?
Of the 48 reports, 11 (22.9%) required hospitalization, and 1 (2.1%) were considered life-threatening.
Is Cerebral atrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Cerebral atrophy?
FINGOLIMOD (87)
VALPROIC ACID (84)
PHENYTOIN (58)
METHOTREXATE (55)
LEVETIRACETAM (54)
CYCLOPHOSPHAMIDE (52)
OLANZAPINE (52)
CARBIDOPA\LEVODOPA (50)
VALPROATE (50)
INTERFERON BETA-1A (46)
Which OCRELIZUMAB Alternatives Have Lower Cerebral atrophy Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE